The Science of Toxicology and U.I. or "Under the Influence and/or Intoxication?" of Cannabis/Marijuana and D.O.A. Drug Testing


Picture

The Official Court Documents that I present to you below here, {THIS ONE TIME, FOR FREE = this offer will not last and is for a limited amount of time = THIS SET OF DOCUMENTS WILL GO MISSING AND A FEE WILL BE CHARGED LATER FOR THIS INFORMATION} The following Documents were presented, accepted and registered by the Criminal or Courts as "Evidence" as they were listed by the Kentucky Courts in a case I recently Advocated in on behalf of James E. Coleman.
Are in fact, the PROOF, that Cannabis/Marijuana/Hemp or Unspecified levels of Cannabinoids are natural within the human body and that their presence or levels or "analytical threshold" combined with the fact that this test measures "no quantification of a specific compound" in the blood, are proof, there has been no measure of  intoxication, performed by this test where cannabiniods are concerned and that this test can not show toxicity.
According to this Expert Witness.
Therefore they are unable to test levels for intoxication as they claim is claimed by the manufacture of the test and/or Law Enforcement in U.I. charges or related cases. These documented facts apply to the Test it’s self given and the Cannabinoid levels… Therefore apply to all these D.O.A. = "Drug of Abuse" Blood Serum U.I. Test used by Law Enforcement and Not the Individual. As these facts apply to all humans and all these Test.

Picture

Picture

PLEASE CONTINUE READING…

The Reintroduction of Psychedelic Drugs Into Society. — News Leak


For thousands of years, human beings have sought after and experienced altered states of consciousness. Meditation, sleep deprivation, fasting and the use of psychedelic substances have all been used in order to alter the mind and body’s regular functions and bring about these altered states. Until fairly recently, the physiological changes in the body underlying these effects, especially in regards to psychedelic substances, were largely unknown due to a significant lack of thorough research into them.

via The Reintroduction of Psychedelic Drugs Into Society. — News Leak

Ananda Hemp Comments on Recent DEA Ruling


News provided by

Ananda Hemp

Dec 19, 2016, 11:26 ET

 

LEXINGTON, Ky., Dec. 19, 2016 /PRNewswire/ — Last Wednesday, December 14th, the Drug Enforcement Administration (DEA) issued a ruling on the coding of “marihuana extracts.” Many questions have arisen in the marketplace from those concerned that the intention of the agency was to seemingly classify hemp-derived extracts containing Cannabidiol (CBD) Schedule I substances.

Ananda Hemp and our parent company Ecofibre have sought legal advice and believe the Final Rule published by DEA doesnot change the legal status of CBD as this can only be done by a scheduling action which has NOT occurred. We are within the belief that the ruling was a mere administrative action and not an attempt to bypass any Congressionally imposed laws such as the 2014 Farm Bill, or any other necessary judicial process.

We strongly believe that our farming operations and products obtained under those operations are, and will continue to be, compliant and legal in all 50 states:

  • Cannabidiol (CBD) is not listed on the federal schedule of controlled substances;
  • Sec. 7606 of the Farm Bill defines hemp as distinct from marijuana and is therefore removed from the definition as a controlled substance when grown under a compliant state program;
  • The 2015 Congressional Appropriations act and corresponding 2016 Appropriations Act specifically defunded the DEA and other governmental agencies from interfering with the processing, use, or sale of industrial hemp that was cultivated in compliance with section 7606 of the 2014 Farm Bill;
  • The code assigned to “marihuana extract” in the rule is “Administration Controlled Substances Code Number” for the purposes of identification of substances on registration forms;
  • Therefore, the Final Rule published on December 14th was not a scheduling action but rather an administrative action related to record keeping

Ecofibre has been working in the state of Kentucky since 2014 and operated under the full extent of section 7606 of the 2014 Farm Bill. To date the company has invested millions of dollars in the region and created a broad range of jobs and farming salaries in Central Kentucky. This year we contracted 500 acres of industrial hemp production and have recently completed yet another successful harvest season. Our brand, Ananda Hemp, has recently entered the marketplace in good favor with consumers and channel partners as we now endeavor to enter into the market research phase of our 5-year pilot program.

Our company will continue to scale our operations in Kentucky and the USA alike by continuing to contract industrial hemp production with American farmers and bringing quality, domestically-produced products to market for sale in all 50 states.

About Ecofibre

Ecofibre is an Australian company that maintains one the world’s largest and most diverse seed banks of cannabis sativa germplasm, which includes several certified industrial hemp cultivars.

Ecofibre has strong research partnerships with several leading Universities and currently utilizes its licenses to grow industrial hemp for the purposes of research and production.

Ecofibre is privately funded by some of Australia’s leading business leaders as well as Joy and Barry Lambert, the most noted cannabis philanthropists in the industry.

Contact
Eric Wang
+61 (0)403 570 377 
eric.wang@ecofibre.com.au

About Ananda Hemp

Ananda Hemp is a premier provider of health and wellness products that are exclusively derived from industrial hemp cultivated compliantly in Kentucky, USA under the accordance of section 7606 of the 2014 Farm Bill.

Contact
John Ryan
+1 858 405 8615
john@anandahemp.com

SOURCE Ananda Hemp

DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances; Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug


Hoban Law Group

December 14, 2016 19:29 ET

DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances; Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug

DENVER, CO–(Marketwired – December 14, 2016) – On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids. Robert Hoban, a cannabis, cannabinoid and hemp lawyer and expert as well as an adjunct professor of law at The University of Denver, states the DOJ and DEA cannot unilaterally make law and schedule controlled substances, thus causing this Final Rule to exceed the DEA’s authority. Instead, such actions require an act of Congress.

As is the case here, the DEA is an agency that has previously sought to exceed its authority contrary to applicable law. It is anticipated that this “final ruling” and determination will be challenged both in court and administratively across the country. With 28 states that already have medical cannabis laws on the books, 8 states passing adult use laws in the November election, and numerous other states enacting industrial hemp legislation, the industry is up for the challenge of litigation against any government agency that operates contrary to prevailing law and enforcement policies.

The DEA’s Final Rule seeks to broadly expand and override existing definitions of controlled substances by newly creating a “Marihuana Extract” classification. The effect of this Final Rule appears to be incorporation of any and all cannabinoids from the Cannabis plant as a Schedule 1 controlled substance, despite the fact that many such cannabinoids are naturally occurring derived from non-“marihuana” portions of the plant or or from entirely different plants altogether. Problematically, the Final Rule fails to acknowledge there exist certain parts of the plant, and certain types of the plant — namely, industrial hemp — which cannot and should not be treated as a “Marihuana Extract.” Notably, the DEA has sought to unilaterally create laws before, and has lost, when challenged.

Hoban surmises, “The feeling is that this is an action beyond the DEA’s authority and we believe this is unlawful and we are taking a course of action for our clients. This Final Rule serves to threaten hundreds, if not thousands, of growing businesses, with massive economic and industry expansion opportunities, all of which conduct lawful business in reliance upon the Federal Government also acting pursuant to law, and as ordered by the Ninth Circuit in 2003 and 2004. We will see the Federal Government in court.”

Image Available: http://www.marketwire.com/library/MwGo/2016/12/14/11G125277/Images/Hoban_Photo-82fa3561cc6d93ea991b06d3c4c27235.jpg

Contact Information

Uniting (and) Strengthening America (by) Providing Appropriate Tools Required (to) Intercept (and) Obstruct Terrorism Act of 2001 (hereafter known as the Patriot Act, because that name is long and dumb)


Data shows Patriot Act used more often to justify drug warrants, not terrorism ones

by Miranda Nelson on September 8th, 2011 at 11:24 AM

 

null

New York Magazine has put out an incredibly detailed compendium of 9/11 information on the eve of the 10th anniversary of the attacks that left over 3,000 people dead. The September 11 attacks, as you’re well aware, were the impetus (or used as justification, depending on how cynical you are) for pushing through the USA PATRIOT ACT, which was hurriedly signed into law on October 26, 2001.

One of the main focuses of the Uniting (and) Strengthening America (by) Providing Appropriate Tools Required (to) Intercept (and) Obstruct Terrorism Act of 2001 (hereafter known as the Patriot Act, because that name is long and dumb) is Title II, which is all about surveillance. That’s right: even though those dastardly terrorists who hate our freedom came from overseas (as was the rhetoric beaten into the collective consciousness post 9/11), the U.S. government thought it was prudent to pass a bunch of surveillance laws so it could spy on its own citizens.

Let me quote the relevant section before we proceed:

SEC. 213. AUTHORITY FOR DELAYING NOTICE OF THE EXECUTION OF A WARRANT.

…(b) DELAY- With respect to the issuance of any warrant or court order under this section, or any other rule of law, to search for and seize any property or material that constitutes evidence of a criminal offense in violation of the laws of the United States, any notice required, or that may be required, to be given may be delayed if–

(1) the court finds reasonable cause to believe that providing immediate notification of the execution of the warrant may have an adverse result (as defined in section 2705);

Delayed-notice search warrants: we won’t tell you we’re breaking into your house to look around if we think there will be adverse results, like you calling up your terrorist buddies to let them know we’re on to you.

Something seems wrong with this graph (courtesy New York Magazine).

But between 2006 and 2009, do you know how many times the Patriot Act was used to issue delayed-notice warrants relating to terrorists and related activities? That would be a whole 15 times—even though the act mentions the word terrorism 161 times and terrorism 175 times.

Aside: did you know that not a single person has been brought to justice on American soil for those deaths?

In the same time period, New York Magazine reports that 1,618 delayed-notice search warrants were issued in relation to drugs and related activity. If you had any doubts about the true mandate of the Patriot Act, doubt no longer. Congratulations America on using a senseless tragedy to justify targeting marijuana users!

And why am I concluding that these people are primarily low-level marijuana offenders and not cocaine smugglers or meth manufacturers? The statistics on arrests and imprisonment make it clear: in 2006, 829,627 marijuana-related arrests were made in the United States, 89 percent of which were for mere possession. Not for growing or selling. Just for holding onto the stuff. In 2010, 50,383 arrests were made in New York City alone for possession.

The Patriot Act: great for the War on Drugs, bad for anyone who likes to smoke a joint, laughable in regards to stopping terrorism.

Follow Miranda Nelson on Twitter at @charenton_.

CONTINUE READING…

Radiation oncologist tells panel that former cancer patient’s trials changed his perspective on medical cannabis


09/21/2016 06:02 PM

526275994

 

FRANKFORT — A radiation oncologist says his experiences watching a cancer patient ultimately lose her battle with the illness while also defending herself against charges of growing marijuana caused his perspective on medical cannabis to change completely.

Dr. Don Stacy, who practices in the Louisville area, told the Interim Joint Committee on Health and Welfare on Wednesday that the woman, a 25-year-old female, had developed head and neck cancer.

And after various prescriptions did nothing to help her cope with complications of her chemotherapy and radiation treatment, she found relief in marijuana.

The cancer ultimately disappeared, and she married and had a kid.

But her ending wasn’t a happy one.

“Unfortunately her cancer recurred after treatment,” Stacy, medical liaison for the Alliance for Innovative Medicine, told lawmakers. “Her husband abandoned her. She then started aggressive treatment again to try to control her recurring disease, which led to a variety of severe side effects. Based on her experience initially, she decided to try to restart to smoke cannabis again.”

The woman, who was sexually assaulted in that time, eventually began growing marijuana at her home, sparking the interest of law enforcement.

“She was arrested, her child was taken away from her, and she ended up dying of her cancer.”

Stacy said the woman wasn’t the only patient who informed him of marijuana use, adding that the patients who self-report using cannabis say it is “highly effective at minimizing their symptoms” that can include nausea and pain.

Medical marijuana is legal in 25 states and the District of Columbia, and the issue has shown marginal progress in recent legislative sessions.

But lawmakers indicated that they’ll need to see more before signing onto a bill legalizing pot for medical use.

Sen. Ralph Alvarado, R-Winchester, said he’s keeping an open mind on the topic and wants to see more clinical trials on medical marijuana. Groups like the American and Kentucky medical associations and those advocating for victims of multiple sclerosis have also said additional trials are needed, Alvarado said.

“They claim it improves (symptoms of multiple sclerosis), and when I’ve asked their folks what is your official stance as an organization, they say we want more studies on this topic to know if it’s going to work or not,” he said.

Senate Majority Whip Jimmy Higdon, who read from a recent Politico article authored by his son, James Higdon, on South Carolina Senator and former presidential candidate Lindsey Graham’s evolution on the subject, says he’s on the fence about medical cannabis.

One important factor will be how it’s defined in legislation.

“Bills like Sen. (Morgan) McGarvey’s bill, I could support a bill like his that deals with end-of-life issues for Hospice patients,” said Higdon, R-Lebanon.

McGarvey’s bill, Senate Bill 304, would have created a classification of medically necessary marijuana and a task force to craft enabling legislation, specifically for end-of-life scenarios, for the 2017 session. SB 204 and other previous efforts to legalize medical cannabis haven’t gotten past their respective committees.

In July, Sen. John Schickel, a Union Republican and chair of the Senate Licensing, Occupations and Administrative Regulations Committee, held an informational heaing on the issue in hopes of advancing debate during the legislative interim.

Rep. Tom Burch, who chairs the House Health and Welfare Committee, said lawmakers will continue to grapple with the subject in upcoming sessions “until we finally do something about it.”

“In 1974 I voted to criminalize marijuana, so I was one of the bad guys I guess,” said Burch, D-Louisville.

CONTINUE READING…

LISTEN TO VIDEO NEWS INTERVIEWS AT THIS LINK

Petitioning to keep Kratom OUT of the Controlled Substance Act and Schedule I – We only have until December 1st!


kratom-plant

Recently I published an article with information pertaining to the rescheduling of Kratom by the U.S. Government via the DEA into Schedule I Status.

Fortunately the change was at least held off long enough for people to be able to make their comments on the subject.

The link to REGULATIONS.GOV where the DEA/Federal Government is accepting comments is only going to be active until December 1st so don’t forget to make your comment soon!

Additionally there is another petition to keep Kratom off the Controlled Substance list.  The link to that petition is here:

Do not place Kratom on the Controlled Substance List

Please sign this petition as well!

We are anti-prohibitionist’s!

sk

It’s high time: If we can legalize marijuana, why can’t we end the misguided War on Drugs?


America’s wasted more than $1 trillion on demonizing drugs, many of which, like weed, have real medical benefits

Thor Benson

It's high time: If we can legalize marijuana, why can't we end the misguided War on Drugs?

On Election Day, my home state of California voted to legalize recreational cannabis, as did Massachusetts, Maine and Nevada. So the 2016 elections represented a substantial victory for the legalization movement, which has managed to pass referendums in seven states. With 57 percent of the country now supporting marijuana legalization, according to Pew, it seems likely there will be a nationwide victory sometime in the next few years. However, the War on Drugs is far from over.

Even if marijuana is legalized throughout the United States, there will still be numerous drugs in this country that remain very much illegal, and Americans will suffer because of this. Drugs like psilocybin mushrooms, LSD and MDMA have all demonstrated great potential when it comes to medical benefits, and shown little potential for harm. Still, the idea of legalizing those drugs any time soon seems as likely as Donald Trump hosting a quinceañera.

“LSD, psilocybin and MDMA, when combined with psychotherapy, have tremendous medical potential for treating psychiatric illnesses in people for whom other treatments have failed,” Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), told me in an email. “These psychedelic drugs need to be legalized, both through scientific drug development studies designed to obtain FDA approval for prescription use and through political means so that they are legalized for non-medical purposes like personal growth, spirituality, couples therapy, creativity, innovation, and celebratory experiences.”

Researchers in Switzerland found in 2014 that LSD can be helpful for patients dealing with end-of-life anxiety related to a terminal illness. The same sort of conclusion has been drawn for psilocybin. Psilocybin has also proven useful for treating severe depression. MDMA has shown great promise for treating PTSD, when used alongside psychotherapy. All of the drugs remain illegal in the United States, and there has been little effort to change that.

Let’s not stop there, though. The War on Drugs has cost America well over $1 trillion since it began under Richard Nixon. This war has been the main cause of our country’s mass incarceration problem. As it is often noted, we have 5 percent of the world’s population and roughly 25 percent of its prisoners. You cannot have a War on Drugs, you can only have a war on people. As Gore Vidal famously used to say of the War on Terror, you cannot have a war on a noun, as that is like saying you’re at war with dandruff. Too many can’t get jobs because of criminal records or lose decades of their lives over small offenses.

We must legalize all drugs. You cannot regulate a drug that is not legal, and you cannot stop addiction by throwing citizens in cages and putting in no effort to rehabilitate them. I am not arguing for the selling of meth and heroin at your local Target store, but I am arguing for a scenario where you are not put in cuffs for having one of those drugs in your pocket.

Portugal decriminalized all drugs nearly decades ago, and the country has not spiraled into hellfire and cannibalism. In fact, drug use decreased, drug-related deaths went down and the instances of HIV infections decreased severely. Of course, the country also initiated harm-reduction programs and invested in reducing addiction, but it appears decriminalizing the drugs didn’t turn every corner into a wanton cocaine party. Perhaps we could learn from this example.

Thanks to abuse of prescription painkillers, this country faces a widespread opioid crisis — and all those drugs are legal. While we divvied out legal pills that people didn’t really need to fill the pockets of greedheads, as Hunter S. Thompson called them, we locked up people using a different version of the same drugs. Many who got addicted to painkillers while on prescription turned to heroin when they couldn’t be prescribed them any more or couldn’t afford them. The whole system is toxic.

I’m calling for a true legalization movement. No longer should lives be ruined because of some minor drug experimentation or because a citizen who needed to make an extra buck sold some substances to a willing buyer. The legalization of marijuana will be a milestone, especially since it’s the most popular drug out there, but we cannot stop there. We should murder the War on Drugs and burn its cadaver. This “war” has been one of the biggest policy failures in American history, and we’ve known this for quite some time. Let’s grow up and move forward. We cannot call ourselves the land of the free when we represent the land of the detained.

More Thor Benson.

CONTINUE READING…

Every 25 seconds in the United States, someone is arrested for the simple act of possessing drugs for their personal use…


Interview: Why the US Should Decriminalize Drug Use

 

Summary

 

Neal Scott may die in prison. A 49-year-old Black man from New Orleans, Neal had cycled in and out of prison for drug possession over a number of years. He said he was never offered treatment for his drug dependence; instead, the criminal justice system gave him time behind bars and felony convictions—most recently, five years for possessing a small amount of cocaine and a crack pipe. When Neal was arrested in May 2015, he was homeless and could not walk without pain, struggling with a rare autoimmune disease that required routine hospitalizations. Because he could not afford his $7,500 bond, Neal remained in jail for months, where he did not receive proper medication and his health declined drastically—one day he even passed out in the courtroom. Neal eventually pled guilty because he would face a minimum of 20 years in prison if he took his drug possession case to trial and lost. He told us that he cried the day he pled, because he knew he might not survive his sentence.[1]

***

Just short of her 30th birthday, Nicole Bishop spent three months in jail in Houston for heroin residue in an empty baggie and cocaine residue inside a plastic straw. Although the prosecutor could have charged misdemeanor paraphernalia, he sought felony drug possession charges instead. They would be her first felonies.

Nicole was separated from her three young children, including her breastfeeding newborn. When the baby visited Nicole in jail, she could not hear her mother’s voice or feel her touch because there was thick glass between them. Nicole finally accepted a deal from the prosecutor: she would do seven months in prison in exchange for a guilty plea for the 0.01 grams of heroin found in the baggie, and he would dismiss the straw charge. She would return to her children later that year, but as a “felon” and “drug offender.” As a result, Nicole said she would lose her student financial aid and have to give up pursuit of a degree in business administration. She would have trouble finding a job and would not be able to have her name on the lease for the home she shared with her husband. She would no longer qualify for the food stamps she had relied on to help feed her children. As she told us, she would end up punished for the rest of her life.

***

Every 25 seconds in the United States, someone is arrested for the simple act of possessing drugs for their personal use, just as Neal and Nicole were. Around the country, police make more arrests for drug possession than for any other crime. More than one of every nine arrests by state law enforcement is for drug possession, amounting to more than 1.25 million arrests each year. And despite officials’ claims that drug laws are meant to curb drug sales, four times as many people are arrested for possessing drugs as are arrested for selling them.

As a result of these arrests, on any given day at least 137,000 men and women are behind bars in the United States for drug possession, some 48,000 of them in state prisons and 89,000 in jails, most of the latter in pretrial detention. Each day, tens of thousands more are convicted, cycle through jails and prisons, and spend extended periods on probation and parole, often burdened with crippling debt from court-imposed fines and fees. Their criminal records lock them out of jobs, housing, education, welfare assistance, voting, and much more, and subject them to discrimination and stigma. The cost to them and to their families and communities, as well as to the taxpayer, is devastating. Those impacted are disproportionately communities of color and the poor.

This report lays bare the human costs of criminalizing personal drug use and possession in the US, focusing on four states: Texas, Louisiana, Florida, and New York. Drawing from over 365 interviews with people arrested and prosecuted for their drug use, attorneys, officials, activists, and family members, and extensive new analysis of national and state data, the report shows how criminalizing drug possession has caused dramatic and unnecessary harms in these states and around the country, both for individuals and for communities that are subject to discriminatory enforcement.

There are injustices and corresponding harms at every stage of the criminal process, harms that are all the more apparent when, as often happens, police, prosecutors, or judges respond to drug use as aggressively as the law allows. This report covers each stage of that process, beginning with searches, seizures, and the ways that drug possession arrests shape interactions with and perceptions of the police—including for the family members and friends of individuals who are arrested. We examine the aggressive tactics of many prosecutors, including charging people with felonies for tiny, sometimes even “trace” amounts of drugs, and detail how pretrial detention and long sentences combine to coerce the overwhelming majority of drug possession defendants to plead guilty, including, in some cases, individuals who later prove to be innocent.

The report also shows how probation and criminal justice debt often hang over people’s heads long after their conviction, sometimes making it impossible for them to move on or make ends meet. Finally, through many stories, we recount how harmful the long-term consequences of incarceration and a criminal record that follow a conviction for drug possession can be—separating parents from young children and excluding individuals and sometimes families from welfare assistance, public housing, voting, employment opportunities, and much more.

Families, friends, and neighbors understandably want government to take actions to prevent the potential harms of drug use and drug dependence. Yet the current model of criminalization does little to help people whose drug use has become problematic. Treatment for those who need and want it is often unavailable, and criminalization tends to drive people who use drugs underground, making it less likely that they will access care and more likely that they will engage in unsafe practices that make them vulnerable to disease and overdose.

While governments have a legitimate interest in preventing problematic drug use, the criminal law is not the solution. Criminalizing drug use simply has not worked as a matter of practice. Rates of drug use fluctuate, but they have not declined significantly since the “war on drugs” was declared more than four decades ago. The criminalization of drug use and possession is also inherently problematic because it represents a restriction on individual rights that is neither necessary nor proportionate to the goals it seeks to accomplish. It punishes an activity that does not directly harm others.

Instead, governments should expand public education programs that accurately describe the risks and potential harms of drug use, including the potential to cause drug dependence, and should increase access to voluntary, affordable, and evidence-based treatment for drug dependence and other medical and social services outside the court and prison system.

After decades of “tough on crime” policies, there is growing recognition in the US that governments need to undertake meaningful criminal justice reform and that the “war on drugs” has failed. This report shows that although taking on parts of the problem—such as police abuse, long sentences, and marijuana reclassification—is critical, it is not enough: Criminalization is simply the wrong response to drug use and needs to be rethought altogether.

Human Rights Watch and the American Civil Liberties Union call on all states and the federal government to decriminalize the use and possession for personal use of all drugs and to focus instead on prevention and harm reduction. Until decriminalization has been achieved, we urge officials to take strong measures to minimize and mitigate the harmful consequences of existing laws and policies. The costs of the status quo, as this report shows, are too great to bear.

 

CONTINUE READING

 

LINK TO PDF VERSION OF REPORT (205 PAGES)

The DEA is withdrawing a proposal to ban another plant after the Internet got really mad


By Christopher Ingraham October 12 at 10:42 AM

The Drug Enforcement Administration is reversing a widely criticized decision that would have banned the use of kratom, a plant that researchers say could help mitigate the effects of the opioid epidemic.

Citing the public outcry and a need to obtain more research, the DEA is withdrawing its notice of intent to ban the drug, according to a preliminary document that will be posted to the Federal Register Thursday.

The move is “shocking,” according to John Hudak, who studies drug policy at the Brookings Institution. “The DEA is not one to second-guess itself, no matter what the facts are.”

The DEA had announced in August that it planned to place kratom in schedule 1 of the Controlled Substances Act, the most restrictive regulatory category, as soon as Sept. 30. But since announcing their intent to ban kratom, the “DEA has received numerous comments from members of the public challenging the scheduling action,” acting administrator Chuck Rosenberg wrote in the notice, “and requesting that the agency consider those comments and accompanying information before taking further action.”

A spokesman for the Drug Enforcement Administration did not immediately respond to requests for comment.

[What it’s like to be high on kratom, according to the people who use it]

Kratom is a plant from southeast Asia that’s related to coffee. It contains a number of chemical compounds that produce effects similar to opiates when ingested.

People who take it have have said kratom helped them overcome addiction to opiates or alcohol and treat otherwise intractable pain. Researchers say that their work with kratom could eventually lead to the development of nonaddictive alternatives to powerful opiate painkillers. Placing kratom in schedule 1 would cripple researchers ability to study the drug, they say.

U.S. lawmakers were among the groups expressing their displeasure with the DEA’s intent to ban kratom. A group of 51 U.S. representatives wrote to the DEA saying that the DEA’s move “threatens the transparency of the scheduling process and its responsiveness to the input of both citizens and the scientific community.”

Another group of nine senators said the DEA’s “use of this emergency authority for a natural substance is unprecedented,” and urged the administration to reconsider.

The DEA will now open up a period for public comment until Dec. 1 of this year. It is also asking the FDA to expedite a “scientific and medical evaluation and scheduling recommendation” for the active chemical compounds in kratom.

At the close of the comment period, a number of things could happen. The DEA could decide to permanently place the plant in a schedule of the Controlled Substances Act, which would require an additional period for lawmakers and the public to weigh in. It could also decide to temporarily schedule kratom, which would not require any additional comment.

It could also decide to leave kratom unregulated.

[Police arrest more people for marijuana use than for all violent crimes — combined]

Advocates for kratom use, who say the plant has helped them treat pain and stop taking more powerful and deadly opiate painkillers said they are elated.

“I am in tears,” Susan Ash of the American Kratom Association said in an email. “Our voices are being heard, but we still have a long road ahead of us.

Lawmakers who criticized the initial announcement to ban kratom are also pleased. “Concerned citizens across the country have made it clear, they want the DEA to listen to the science when it comes to the potentially life-saving properties of kratom,” said Mark Pocan (D.-Wis.) in an email.

Researchers are welcoming the move, but they point out that the future of their work with the plant is an uncertain one.

“It’s certainly a positive development,” said Andrew Kruegel of Columbia University in an email. Kruegel is one of the researchers working to develop next-generation painkillers based on compounds contained in kratom.

Kruegel says that the FDA’s evaluation of the drug will carry a lot of weight in the DEA’s decision. But the kind of rigorous, controlled trials that the FDA typically refers to in situations like this simply don’t exist for kratom.

“Unfortunately, in the United States I don’t think we have a good regulatory framework for handling this situation or taking perhaps more reasonable middle paths” between banning the drug outright or keeping it unregulated, Kruegel says.

Still, he says, “the FDA is a scientific agency rather than a law enforcement agency, so I am encouraged that they will now be having more serious input on this important policy decision.”

Marc Swogger, a clinical psychologist at the University of Rochester Medical Center who has published research on kratom use and earlier called the decision to ban the plant “insane,” said in an email that “I’m happy to see this. It is a step in the right direction and a credit to people who have spoken out against scheduling this plant.”

CONTINUE READING…

New Study Confirms Marijuana Use Up Drastically in Workforce


Cully Stimson / @cullystimson / October 12, 2016 / comments

This November, there are a record number of ballot initiatives in at least nine states regarding so-called medical marijuana or outright legalization of the Schedule I drug. The pot pushers, both small businesses and large, want more people smoking, eating, and consuming more pot because it is good for their bottom line.

Before voting yes, voters—and, in particular, employers—should take a look at more disturbing data that was released two weeks ago at a national conference.

At the annual Substance Abuse Program Administrators Association conference, Quest Diagnostics—one of the nation’s largest drug-testing companies—unveiled the results of its Drug Testing Index. The index examines illicit drug use by workers in America each year.

In 2015, Quest examined more than 9.5 million urine, 900,000 oral fluid, and 200,000 hair drug samples. Following years of decline in overall illegal drug usage, the results showed that the percentage of employees testing positive for illicit drugs has steadily increased over the last three years to a 10-year high.

The Drug Testing Index is an analysis of test results from three categories of workers—including federally mandated, safety-sensitive workers, the general workforce, and the combined U.S. workforce

Oral fluid drug testing results—best at detecting recent drug usage—showed an overall positivity rate increase of 47 percent over the last three years in the general workforce to 9.1 percent in 2015 from 6.7 percent in 2013.

According to Quest, the increase was “largely driven by double-digit increases in marijuana positivity.” In fact, according to the report, in 2015 there was a “25 percent relative increase in marijuana detection as compared to 2014.” The report also showed a significant increase in heroin positivity in urine tests for federally mandated safety-sensitive employees.

Another disturbing trend is the rising positivity rate for post-accident urine drug testing in both the general U.S. and the federal mandated, safety-sensitive workforces. According to the index, post-accident positivity increased 6.2 percent in 2015, compared to 2014, and increased a whopping 30 percent since 2011.

To those of us who have warned about the growing liberalization of the use of marijuana, from so-called “medical marijuana” to recreational abuse of the Schedule I drug, the results of the index are all too predictable.

It is also not surprising that none of the major organizations that push for pot legalization and decriminalization of marijuana have written major stories about the Quest Diagnostics report.

The more people use marijuana, the more likely it is that those who work and are subject to testing will pop positive for marijuana, even in safety-sensitive jobs. Think about that next time you hop on an airplane, ride Amtrak, or go about your daily life thinking everyone is focused on their job and your safety.

CONTINUE READING…